DrugPatentWatch Database Preview

Details for Patent: 8,372,431

« Back to Dashboard

Which drugs does patent 8,372,431 protect, and when does it expire?

Patent 8,372,431 protects APTIOM and is included in one NDA.

This patent has thirty-one patent family members in twenty-three countries.

Summary for Patent: 8,372,431

Title:	Pharmaceutical composition comprising licarbazepine acetate
Abstract:	A pharmaceutical composition comprising licarbazepine acetate, especially eslicarbazepine acetate, in combination with suitable excipients, in particular a binder, and a disintegrant. Also disclosed is a granulation process, especially a wet granulation process, for making the pharmaceutical composition.
Inventor(s):	Cardoso de Vasconcelos; Teofilo (S. Mamede do Coronado, PT), dos Santos Lima; Ricardo Jorge (S. Mamede do Coronado, PT), Cerdeira de Campos Costa; Rui (S. Mamede do Coronado, PT)
Assignee:	BIAL-Portela & C.A., S.A. (S. Mamede do Coronado, PT)
Application Number:	12/257,240
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,372,431
Patent Claim Types: see list of patent claims	Composition; Formulation; Device; Dosage form;

Drugs Protected by US Patent 8,372,431

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Sunovion Pharms Inc	APTIOM	eslicarbazepine acetate	TABLET;ORAL	022416-001	Nov 8, 2013		RX	Yes	No			Y
Sunovion Pharms Inc	APTIOM	eslicarbazepine acetate	TABLET;ORAL	022416-002	Nov 8, 2013		RX	Yes	No			Y
Sunovion Pharms Inc	APTIOM	eslicarbazepine acetate	TABLET;ORAL	022416-003	Nov 8, 2013		RX	Yes	No			Y

International Family Members for US Patent 8,372,431

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	069031
Australia	2008317584
Brazil	PI0818680